MEDICAL NEWS TODAY | DAILY NEWS
Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early Alzheimer's disease.
 
MEDICALNEWSTODAY | DAILY NEWS
 
 
 
 
First Alzheimer’s pill for genetically at high risk shows promise in phase 3 trial
 
READ ON
→
Weight loss drugs improve heart health regardless of amount of weight lost: study
 
READ ON
→
How old do you have to be to use Ozempic?
 
READ ON
→
 
 
 
 
 
What to know about swallowing and Huntington’s disease